Drug development cycle

Pre-clinical

Before testing a drug on people, researchers must find out whether it has the potential to cause serious harm, this is preclinical development.

How can DISQOVER help?

Access all available data, investigate hypotheses, make informed decisions, and set up success potential for a new drug.

Previous phase
  1. 1
  2. 1
  3. 1
  4. 1
  5. 1
Next phase
Book a meeting

Let’s connect and figure it out.

Pre-clinical use cases

 DISQOVER can assist the researcher's journey by visualizing drug candidate potentials across multiple facets. All scientific knowledge, ELN information, and related data are consolidated and available within the dashboard, supporting insights and decisions for efficacy, formulation, route, exposure, and biomarker identification up to the intended clinical design.

WHITEPAPER

The importance of biomarker selection in healthcare

Biomarkers have repeatedly demonstrated their value in healthcare product development over the last decades. From early preclinical development to post-marketing studies, biomarkers significantly increase the success rates of clinical evaluations by up to 20%, reducing the main cost per patient and facilitating regulatory approval. In this whitepaper, learn more about biomarkers' necessity in pharmacological and medical product development, the processes for biomarker selection and identification, and how to overcome some of the major challenges associated with these activities.

Download
Whitepaper | The importance of biomarker selection in healthcare

Explore what's possible with DISQOVER

Book a demo

ONTOFORCE enables life science companies to unlock hidden insights from data.


With DISQOVER, built on knowledge graph technology, we support life sciences and pharmaceutical companies with innovative data management and visualization.

SOLUTIONS
PRODUCT
RESOURCES
COMPANY

© 2024 ONTOFORCE All right reserved